Hérédia A, Burtin P
Institut de Recherches Scientifiques sur le Cancer (ER 277), Villejuif, France.
Pathol Biol (Paris). 1988 Nov;36(9):1147-50.
We analyze here recent data from literature concerning the role of collagenases in cancer. The alteration of basement membrane (BM) and extracellular matrix components, in particular collagens, has been widely reported during tumor invasion. The collagenases degrade interstitial collagens (types I and III) and BM collagens (type IV). So, they break natural barriers and allow tumor cells to spread in surrounding tissues and metastasize. Classical collagenases are not able to degrade type IV collagen (the main component of BM) which, however, often appears to be very altered around tumor cells. Therefore, the existence of a specific type IV collagenase is necessary to explain this phenomenon. Most studies performed with the object of proving the role of collagenases in tumor invasion and metastasis have shown the presence of a type I collagenase, but type IV collagenase has been more difficult to evidence.
我们在此分析近期文献中有关胶原酶在癌症中作用的数据。在肿瘤侵袭过程中,基底膜(BM)和细胞外基质成分,特别是胶原蛋白的改变已被广泛报道。胶原酶可降解间质胶原(I型和III型)和BM胶原(IV型)。因此,它们打破了天然屏障,使肿瘤细胞能够在周围组织中扩散并转移。经典的胶原酶无法降解IV型胶原(BM的主要成分),然而,IV型胶原在肿瘤细胞周围往往表现出非常大的改变。因此,必须存在一种特定的IV型胶原酶才能解释这一现象。大多数旨在证明胶原酶在肿瘤侵袭和转移中作用的研究都表明存在I型胶原酶,但IV型胶原酶更难被证实。